Home Cart Sign in  
Chemical Structure| 1338247-30-5 Chemical Structure| 1338247-30-5

Structure of BMS-3
CAS No.: 1338247-30-5

Chemical Structure| 1338247-30-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BMS-3 is a specific and potent LIMK inhibitor with IC50 value of 5nM and 6nM for LIMK1 and LIMK2, respectively.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of BMS-3

CAS No. :1338247-30-5
Formula : C17H12Cl2F2N4OS
M.W : 429.27
SMILES Code : O=C(C1CC1)NC2=NC=C(C3=CC(C(F)F)=NN3C4=C(Cl)C=CC=C4Cl)S2
MDL No. :MFCD17019326
InChI Key :YBGGBHCJSAEIAS-UHFFFAOYSA-N
Pubchem ID :73265272

Safety of BMS-3

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Mouse sperm 1 or 50 μM 60 min Inhibition of pLIMK1 resulted in significantly lower levels of F-actin polymerization Dev Biol. 2015 Sep 15;405(2):237-49
trophoblast cells 2.5 µM, 5 µM, 10 µM 6 h Inhibition of endogenous LIMK2 in differentiated trophoblast cells, results showed that BMS-3 treatment reduced the levels of pLIMK2Thr505 and pCOFILINSer3, and decreased the expression of trophoblast giant cell marker Prl2c2. Stem Cell Res Ther. 2022 May 7;13(1):189

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.33mL

0.47mL

0.23mL

11.65mL

2.33mL

1.16mL

23.30mL

4.66mL

2.33mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories